Last Updated: August 10, 2026

Roxane Company Profile

✉ Email this page to a colleague

« Back to Dashboard

What is the competitive landscape for ROXANE

ROXANE has one hundred and twenty-six approved drugs.

There are nine tentative approvals on ROXANE drugs.

Summary for Roxane

US Patents:	0
Tradenames:	74
Ingredients:	67
NDAs:	126
Patent Litigation for Roxane:	See patent lawsuits for Roxane
PTAB Cases with Roxane as petitioner:	See PTAB cases with Roxane as petitioner

Drugs and US Patents for Roxane

+ Get email alerts for changes to this table

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Roxane	PROPRANOLOL HYDROCHLORIDE	propranolol hydrochloride	TABLET;ORAL	070520-001	Jul 7, 1986		DISCN	No	No		⤷ Start Trial				⤷ Start Trial
Roxane	ISOETHARINE HYDROCHLORIDE	isoetharine hydrochloride	SOLUTION;INHALATION	088226-001	Sep 16, 1983		DISCN	No	No		⤷ Start Trial				⤷ Start Trial
Roxane	NEFAZODONE HYDROCHLORIDE	nefazodone hydrochloride	TABLET;ORAL	076196-005	Sep 16, 2003		DISCN	No	No		⤷ Start Trial				⤷ Start Trial
Roxane	PREDNISONE	prednisone	TABLET;ORAL	087833-001	May 4, 1982		DISCN	Yes	No		⤷ Start Trial				⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Roxane

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.